JP2005503809A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005503809A5 JP2005503809A5 JP2003530824A JP2003530824A JP2005503809A5 JP 2005503809 A5 JP2005503809 A5 JP 2005503809A5 JP 2003530824 A JP2003530824 A JP 2003530824A JP 2003530824 A JP2003530824 A JP 2003530824A JP 2005503809 A5 JP2005503809 A5 JP 2005503809A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- ramp1
- humanized
- amino acid
- humanized ramp1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 101000584583 Homo sapiens Receptor activity-modifying protein 1 Proteins 0.000 claims 26
- 102100030697 Receptor activity-modifying protein 1 Human genes 0.000 claims 20
- 210000004027 cell Anatomy 0.000 claims 13
- 125000000539 amino acid group Chemical group 0.000 claims 12
- 230000009261 transgenic effect Effects 0.000 claims 9
- 239000013604 expression vector Substances 0.000 claims 7
- 102000050292 human RAMP1 Human genes 0.000 claims 6
- 238000011830 transgenic mouse model Methods 0.000 claims 6
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 claims 6
- 108020004414 DNA Proteins 0.000 claims 5
- 239000012528 membrane Substances 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- 102100024654 Calcitonin gene-related peptide type 1 receptor Human genes 0.000 claims 4
- 101000760563 Homo sapiens Calcitonin gene-related peptide type 1 receptor Proteins 0.000 claims 4
- 101150026505 Ramp1 gene Proteins 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 108010078311 Calcitonin Gene-Related Peptide Receptors Proteins 0.000 claims 3
- 241001465754 Metazoa Species 0.000 claims 3
- 238000009395 breeding Methods 0.000 claims 3
- 230000001488 breeding effect Effects 0.000 claims 3
- 102000008323 calcitonin gene-related peptide receptor activity proteins Human genes 0.000 claims 3
- 210000001082 somatic cell Anatomy 0.000 claims 3
- 102000053602 DNA Human genes 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 210000002308 embryonic cell Anatomy 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 239000013598 vector Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32529501P | 2001-09-27 | 2001-09-27 | |
| PCT/US2002/030501 WO2003027252A2 (en) | 2001-09-27 | 2002-09-26 | Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005503809A JP2005503809A (ja) | 2005-02-10 |
| JP2005503809A5 true JP2005503809A5 (enExample) | 2005-12-22 |
| JP4603261B2 JP4603261B2 (ja) | 2010-12-22 |
Family
ID=23267273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003530824A Expired - Fee Related JP4603261B2 (ja) | 2001-09-27 | 2002-09-26 | ヒト化カルシトニン遺伝子関連ペプチド受容体をコードする単離ｄｎａ分子、関連する非ヒトトランスジェニック動物及びアッセイ方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7193070B2 (enExample) |
| EP (1) | EP1438325B1 (enExample) |
| JP (1) | JP4603261B2 (enExample) |
| AT (1) | ATE453661T1 (enExample) |
| CA (1) | CA2461917C (enExample) |
| DE (1) | DE60234944D1 (enExample) |
| WO (1) | WO2003027252A2 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1642983A (zh) | 2002-01-25 | 2005-07-20 | G2治疗有限公司 | 抗C5aR抗体及其应用 |
| US7220862B2 (en) | 2002-06-05 | 2007-05-22 | Bristol-Myers Squibb Company | Calcitonin gene related peptide receptor antagonists |
| US7842808B2 (en) | 2002-06-05 | 2010-11-30 | Bristol-Myers Squibb Company | Anti-migraine spirocycles |
| ES2616539T3 (es) | 2002-06-05 | 2017-06-13 | Bristol-Myers Squibb Company | Antagonistas de receptores de péptidos relacionados con el gen de calcitonina |
| WO2004097421A2 (en) * | 2003-04-29 | 2004-11-11 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with calcitonin receptor-like receptor (calcrl) |
| US7569578B2 (en) | 2003-12-05 | 2009-08-04 | Bristol-Meyers Squibb Company | Heterocyclic anti-migraine agents |
| CN100558428C (zh) | 2003-12-05 | 2009-11-11 | 布里斯托尔-迈尔斯·斯奎布公司 | 降钙素基因相关肽受体拮抗剂 |
| EP1701611B1 (en) * | 2003-12-24 | 2011-05-18 | G2 Inflammation Pty Ltd | Transgenic non-human mammal comprising a polynucleotide encoding human or humanized c5ar |
| TW200533398A (en) | 2004-03-29 | 2005-10-16 | Bristol Myers Squibb Co | Novel therapeutic agents for the treatment of migraine |
| US7384931B2 (en) | 2004-11-03 | 2008-06-10 | Bristol-Myers Squibb Company | Constrained compounds as CGRP-receptor antagonists |
| US7384930B2 (en) | 2004-11-03 | 2008-06-10 | Bristol-Myers Squibb Company | Constrained compounds as CGRP-receptor antagonists |
| US7449586B2 (en) | 2004-12-03 | 2008-11-11 | Bristol-Myers Squibb Company | Processes for the preparation of CGRP-receptor antagonists and intermediates thereof |
| FR2882628B1 (fr) * | 2005-03-04 | 2011-03-18 | Centre Nat Rech Scient | Souris transgeniques et leurs applications comme modele experimental |
| US7834007B2 (en) | 2005-08-25 | 2010-11-16 | Bristol-Myers Squibb Company | CGRP antagonists |
| DK3045182T3 (en) | 2005-11-14 | 2018-03-19 | Teva Pharmaceuticals Int Gmbh | ANTAGONIST ANTIBODIES AGAINST CALCITONIN GEN-RELATED PEPTIDE TO TREAT HEAT |
| JP2009201355A (ja) * | 2006-06-02 | 2009-09-10 | Osaka Univ | 高血圧モデル非ヒト動物 |
| CN104059149B (zh) | 2006-08-22 | 2017-04-12 | 诺沃诺蒂斯克股份有限公司 | 具有改进性能的抗‑C5aR抗体 |
| EP2152882A2 (en) * | 2007-04-26 | 2010-02-17 | Achillion Pharmaceuticals, Inc. | Cells expressing chimeric proteins and assays using such cells |
| CN101970494B (zh) | 2008-02-20 | 2015-01-21 | G2炎症私人有限公司 | 人源化抗-C5aR抗体 |
| WO2009109911A1 (en) | 2008-03-04 | 2009-09-11 | Pfizer Limited | Methods of treating chronic pain |
| JO3382B1 (ar) * | 2008-12-23 | 2019-03-13 | Amgen Inc | أجسام مضادة ترتبط مع مستقبل cgrp بشري |
| IN2012DN02521A (enExample) | 2009-08-28 | 2015-08-28 | Rinat Neuroscience Corp | |
| DK3424953T3 (en) | 2011-06-06 | 2020-11-02 | Novo Nordisk As | Terapeutiske antistoffer |
| JP6267986B2 (ja) * | 2014-02-13 | 2018-01-24 | 株式会社特殊免疫研究所 | ヒトの特定分子と結合する分子標的物質のｉｎｖｉｖｏ評価法 |
| US9896502B2 (en) | 2014-03-21 | 2018-02-20 | Teva Pharmaceuticals International Gmbh | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| US10556945B2 (en) | 2014-03-21 | 2020-02-11 | Teva Pharmaceuticals International Gmbh | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| AU2015318008B2 (en) | 2014-09-15 | 2021-05-20 | Amgen Inc. | Bi-specific anti-CGRP receptor/PAC1 receptor antigen binding proteins and uses thereof |
| JOP20200116A1 (ar) | 2015-04-24 | 2017-06-16 | Amgen Inc | طرق لعلاج أو الوقاية من الصداع النصفي |
| WO2018055574A1 (en) | 2016-09-23 | 2018-03-29 | Teva Pharmaceuticals International Gmbh | Treating refractory migraine |
| MA52202A (fr) | 2018-04-02 | 2021-02-17 | Amgen Inc | Compositions d'érénumab et utilisations de celles-ci |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4882609A (en) * | 1984-11-19 | 1989-11-21 | Max-Planck Gesellschaft Zur Forderung Der Wissenschafter E.V. | Semiconductor devices with at least one monoatomic layer of doping atoms |
| US4908678A (en) * | 1986-10-08 | 1990-03-13 | Semiconductor Energy Laboratory Co., Ltd. | FET with a super lattice channel |
| US5081513A (en) * | 1991-02-28 | 1992-01-14 | Xerox Corporation | Electronic device with recovery layer proximate to active layer |
| US5606177A (en) * | 1993-10-29 | 1997-02-25 | Texas Instruments Incorporated | Silicon oxide resonant tunneling diode structure |
| US6255150B1 (en) * | 1997-10-23 | 2001-07-03 | Texas Instruments Incorporated | Use of crystalline SiOx barriers for Si-based resonant tunneling diodes |
-
2002
- 2002-09-26 WO PCT/US2002/030501 patent/WO2003027252A2/en not_active Ceased
- 2002-09-26 EP EP02763731A patent/EP1438325B1/en not_active Expired - Lifetime
- 2002-09-26 CA CA2461917A patent/CA2461917C/en not_active Expired - Fee Related
- 2002-09-26 US US10/490,594 patent/US7193070B2/en not_active Expired - Fee Related
- 2002-09-26 AT AT02763731T patent/ATE453661T1/de not_active IP Right Cessation
- 2002-09-26 JP JP2003530824A patent/JP4603261B2/ja not_active Expired - Fee Related
- 2002-09-26 DE DE60234944T patent/DE60234944D1/de not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005503809A5 (enExample) | ||
| CA2461917A1 (en) | Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods | |
| AU2022221378B2 (en) | Humanized SIRPA-IL15 knockin mice and methods of use thereof | |
| JP4318736B2 (ja) | ヒト抗体遺伝子を発現する非ヒト動物とその利用 | |
| Janatpour et al. | A repertoire of differentially expressed transcription factors that offers insight into mechanisms of human cytotrophoblast differentiation | |
| Suemizu et al. | Expression profiling of placentomegaly associated with nuclear transplantation of mouse ES cells | |
| JP2022130725A (ja) | 操作されたイムノグロブリンラムダ軽鎖座位を有する非ヒト動物 | |
| PT1802193E (pt) | Método para gerar um murganho homozigótico para uma modificação genética | |
| CN113105555B (zh) | Mhc分子人源化的非人动物的构建方法及应用 | |
| Guo et al. | Obox4 promotes zygotic genome activation upon loss of Dux | |
| Dijkstra et al. | Identification of a gene for an ancient cytokine, interleukin 15-like, in mammals; interleukins 2 and 15 co-evolved with this third family member, all sharing binding motifs for IL-15Rα | |
| CN106715698A (zh) | 用于生产短毛动物的材料和方法 | |
| WO2005003342A1 (ja) | メチル化を利用したトランスジェニック生物を作製する方法およびシステム | |
| EP4588345A1 (en) | Genetically modified non-human mammals, preparation methods therefor, and applications thereof | |
| Goto et al. | Hypomorphic phenotype of Foxn1 gene-modified rats by CRISPR/Cas9 system | |
| CN106978416B (zh) | 一种基因定位整合表达系统及其应用 | |
| WO2022057903A1 (en) | Genetically modified non-human animal with human or chimeric glp1r | |
| CN114747541B (zh) | 一种psgl-1人源化非人类动物模型的构建方法及应用 | |
| CN105524897A (zh) | 转录激活因子样效应因子核酸酶及其应用 | |
| Abe et al. | Establishment of an efficient BAC transgenesis protocol and its application to functional characterization of the mouse Brachyury locus | |
| AU2004225648B2 (en) | Method and system for rapidly conferring a desired trait to an organism | |
| JP2002523094A5 (enExample) | ||
| Yao et al. | Polymorphisms of LAP3 gene and their association with the growth traits in the razor clam Sinonovacula constricta | |
| JP4447705B2 (ja) | 糖尿病発症モデル哺乳動物 | |
| WO2024234997A1 (zh) | 一种靶向猪pLEG1abc基因座的sgRNA、重组表达载体及其制备方法和应用 |